RETAIN Program for Work-related Injuries
(MN RETAIN Trial)
Trial Summary
What is the purpose of this trial?
MN RETAIN Phase 2 Sub-study is a non-randomized trial to evaluate the impact of RETAIN program expansion and services on workforce retention and reduction of future workplace disability in the state of MN. The program is funded by US Department of Labor (US DOL) and sponsored jointly with the US Social Security Administration. There will be collaboration between partners to implement best practices in early intervention to support injured or ill employees in stay-at-work and return-to-work. MN RETAIN involves a partnership between Mayo Clinic and MN Department of Employment and Economic Development (DEED), MN Department of Labor and Industry (DLI), MN Department of Health (MDH), Workforce Development, Inc. (WDI), and the Governor's Workforce Development Board. MN DEED serves as the main recipient and administrator of the funding within the state with Mayo Clinic, DLI, and WDI, as subrecipients of the grant. (Effective Date: 12/23/2021-05/16/2024) MN RETAIN Phase 2 : This study is a randomized control trial (RCT) to evaluate the impact of RETAIN program expansion and services on workforce retention and reduction of future workplace disability in the state of MN. The program is funded by US Department of Labor (US DOL) and sponsored jointly with the US Social Security Administration. There will be collaboration between partners to implement best practices in early intervention to support injured or ill employees in stay-at-work and return-to-work. MN RETAIN involves a partnership between Mayo Clinic and MN Department of Employment and Economic Development (DEED), MN Department of Labor and Industry (DLI), MN Department of Health (MDH), Workforce Development, Inc. (WDI), and the Governor's Workforce Development Board. MN DEED serves as the main recipient and administrator of the funding within the state with Mayo Clinic, DLI, and WDI, as subrecipients of the grant. During this Phase: additional collaborators: Mathematica Policy Research
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your healthcare provider.
What data supports the effectiveness of the RETAIN Program treatment for work-related injuries?
Research shows that programs focusing on returning to work after injury, like the RETAIN Program, can lead to better health outcomes and reduced time away from work. Studies have found that structured return-to-work programs and vocational rehabilitation can decrease delays, improve employment outcomes, and reduce unnecessary medical interventions.12345
How does the RETAIN Program for work-related injuries differ from other treatments?
The RETAIN Program is unique because it focuses on helping people with work-related injuries return to and stay at work by using strategies tailored to their employment status, rather than just addressing the injury itself. It involves Return-to-Work Coordinators who provide personalized support, which is different from traditional treatments that may not include such comprehensive employment-focused assistance.678910
Research Team
Clayton Cowl, MD,MS
Principal Investigator
Mayo Clinic
Laura Breeher, MD, MPH
Principal Investigator
Mayo Clinic
Eligibility Criteria
The Minnesota RETAIN Phase 2 trial is for Minnesota residents who have had or will have surgery affecting their work within the last 12 weeks or next 8 weeks. Participants must have worked in MN at least one day in the past 3 months, be over 18, and employed or active in the labor force. It's not for those with worker's comp having a QRC/DCM, involved in related litigation, unable to consent, employed by certain organizations with return-to-work programs, or on SSDI/SSI.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Intervention
Participants are assigned a dedicated Minnesota RETAIN Return-to-Work Case Manager and referred for additional career and workforce development resources as needed
Follow-up
Participants are monitored for workforce retention and reduction of workplace disability
Long-term Follow-up
Participants are monitored for long-term work disability reduction
Treatment Details
Interventions
- RETAIN Program
Find a Clinic Near You
Who Is Running the Clinical Trial?
Mayo Clinic
Lead Sponsor
Minnesota Department of Employment and Economic Development
Collaborator
Minnesota Department of Health
Collaborator
Mathematica Policy Research
Collaborator
United States Department of Labor
Collaborator
Minnesota Department of Labor and Industry
Collaborator
United States Social Security Administration
Collaborator
Workforce Development, Inc.
Collaborator